...
首页> 外文期刊>Molecules >Synthesis of [13C4]-labeled ?9-Tetrahydrocannabinol and 11-nor-9-Carboxy-?9-tetrahydrocannabinol as Internal Standards for Reducing Ion Suppressing/Alteration Effects in LC/MS-MS Quantification
【24h】

Synthesis of [13C4]-labeled ?9-Tetrahydrocannabinol and 11-nor-9-Carboxy-?9-tetrahydrocannabinol as Internal Standards for Reducing Ion Suppressing/Alteration Effects in LC/MS-MS Quantification

机译:合成[13C4]标记的β9-四氢大麻酚和11-nor-9-羧基-β9-四氢大麻酚作为内标,用于降低LC / MS-MS定量中的离子抑制/改变作用

获取原文
           

摘要

(?)-?9-Tetrahydrocannabinol is the principal psychoactive component of the cannabis plant and also the active ingredient in some prescribed drugs. To detect and control misuse and monitor administration in clinical settings, reference samples of the native drugs and their metabolites are needed. The accuracy of liquid chromatography/mass spectrometric quantification of drugs in biological samples depends among others on ion suppressing/alteration effects. Especially, 13C-labeled drug analogues are useful for minimzing such interferences. Thus, to provide internal standards for more accurate quantification and for identification purpose, synthesis of [13C4]-?9-tetrahydro-cannabinol and [13C4]-11-nor-9-carboxy-?9-tetrahydrocannabinol was developed via [13C4]-olivetol. Starting from [13C4]-olivetol the synthesis of [13C4]-11-nor-9-carboxy-?9-tetrahydrocannabinol was shortened from three to two steps by employing nitromethane as a co-solvent in condensation with (+)-apoverbenone. View Full-Text
机译:(?)-?9-四氢大麻酚是大麻植物的主要精神活性成分,也是某些处方药中的活性成分。为了检测和控制滥用并监测临床环境中的给药,需要天然药物及其代谢物的参考样品。液相色谱/质谱法定量生物样品中药物的准确性尤其取决于离子抑制/改变作用。尤其是13C标记的药物类似物可用于最大程度地减少此类干扰。因此,为了提供用于更准确定量和鉴定目的的内标,通过[13C4]开发了[13C4]-?9-四氢大麻酚和[13C4] -11-nor-9-羧基-?9-四氢大麻酚的合成。 -olivetol。从[13C4] -olivetol开始,通过使用硝基甲烷作为共溶剂与(+)-apoverbenone缩合,将[13C4] -11-nor-9-羧基-α9-四氢大麻酚的合成从三步缩短为两步。查看全文

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号